Folgen
Marc Swidergall
Marc Swidergall
Assistant Professor, David Geffen School of Medicine at UCLA, Harbor-UCLA
Bestätigte E-Mail-Adresse bei lundquist.org - Startseite
Titel
Zitiert von
Zitiert von
Jahr
EphA2 is an epithelial cell pattern recognition receptor for fungal β-glucans
M Swidergall, NV Solis, MS Lionakis, SG Filler
Nature microbiology 3 (1), 53-61, 2018
1432018
Interplay between Candida albicans and the antimicrobial peptide armory
M Swidergall, JF Ernst
Eukaryotic cell 13 (8), 950-957, 2014
1392014
Oropharyngeal candidiasis: fungal invasion and epithelial cell responses
M Swidergall, SG Filler
PLoS pathogens 13 (1), e1006056, 2017
1102017
Msb2 Shedding Protects Candida albicans against Antimicrobial Peptides
E Szafranski-Schneider, M Swidergall, F Cottier, D Tielker, E Román, ...
PLoS pathogens 8 (2), e1002501, 2012
1002012
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
TJ Break, V Oikonomou, N Dutzan, JV Desai, M Swidergall, T Freiwald, ...
Science 371 (6526), eaay5731, 2021
962021
Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection
M Swidergall, M Khalaji, NV Solis, DL Moyes, RA Drummond, B Hube, ...
The Journal of infectious diseases 220 (9), 1477-1488, 2019
822019
GRP78 and integrins play different roles in host cell invasion during mucormycosis
A Alqarihi, T Gebremariam, Y Gu, M Swidergall, S Alkhazraji, ...
MBio 11 (3), 10.1128/mbio. 01087-20, 2020
742020
Aspergillus fumigatus CalA binds to integrin α5β1 and mediates host cell invasion
H Liu, MJ Lee, NV Solis, QT Phan, M Swidergall, B Ralph, AS Ibrahim, ...
Nature microbiology 2 (2), 1-10, 2016
722016
Innate Immunity to Mucosal Candida Infections
A Verma, SL Gaffen, M Swidergall
Journal of Fungi 3 (4), 60, 2017
632017
Candida albicans mucin Msb2 is a broad-range protectant against antimicrobial peptides
M Swidergall, AM Ernst, JF Ernst
Antimicrobial agents and chemotherapy 57 (8), 3917-3922, 2013
612013
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
SSM Soliman, C Baldin, Y Gu, S Singh, T Gebremariam, M Swidergall, ...
Nature microbiology 6 (3), 313-326, 2021
562021
The aryl hydrocarbon receptor governs epithelial cell invasion during oropharyngeal candidiasis
NV Solis, M Swidergall, VM Bruno, SL Gaffen, SG Filler
MBio 8 (2), 10.1128/mbio. 00025-17, 2017
532017
Candida albicans at Host Barrier Sites: Pattern Recognition Receptors and Beyond
M Swidergall
Pathogens 8 (1), 40, 2019
502019
Mucosal IgA prevents commensal Candida albicans dysbiosis in the oral cavity
N Millet, NV Solis, M Swidergall
Frontiers in Immunology 11, 555363, 2020
492020
EphA2 is a neutrophil receptor for Candida albicans that stimulates antifungal activity during oropharyngeal infection
M Swidergall, NV Solis, Z Wang, QT Phan, ME Marshall, MS Lionakis, ...
Cell reports 28 (2), 423-433. e5, 2019
492019
Inhibition of EGFR signaling protects from mucormycosis
TN Watkins, T Gebremariam, M Swidergall, AC Shetty, KT Graf, A Alqarihi, ...
MBio 9 (4), 10.1128/mbio. 01384-18, 2018
472018
Selection of Candida albicans trisomy during oropharyngeal infection results in a commensal-like phenotype
A Forche, NV Solis, M Swidergall, R Thomas, A Guyer, A Beach, ...
PLoS genetics 15 (5), e1008137, 2019
442019
Activation of EphA2-EGFR signaling in oral epithelial cells by Candida albicans virulence factors
M Swidergall, NV Solis, N Millet, MY Huang, J Lin, QT Phan, MD Lazarus, ...
PLoS Pathogens 17 (1), e1009221, 2021
422021
The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection
P Uppuluri, L Lin, A Alqarihi, G Luo, EG Youssef, S Alkhazraji, NY Yount, ...
PLoS pathogens 14 (5), e1007056, 2018
422018
Candida albicans white-opaque switching influences virulence but not mating during oropharyngeal candidiasis
NV Solis, YN Park, M Swidergall, KJ Daniels, SG Filler, DR Soll
Infection and immunity 86 (6), 10.1128/iai. 00774-17, 2018
362018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20